Gregory Crimmins, PhD
CEO & Founder
Remedy Plan Therapeutics
Greg has a PhD in molecular biology from University of California, Berkeley, where he helped invent a promising new way to treat cancer with immunotherapy. He has 20 years of experience in biomedical research, including phenotypic screening, cell biology, and immunology. Greg has led Remedy Plan from inception through development of its drug screening platform to the optimization of novel first-in-class cancer therapeutics.
Sessions
-
23-Jun-2026Theater 3Remedy Plan Therapeutics
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}